Cite
HARVARD Citation
Girard, P. et al. (n.d.). Week 96 efficacy and safety of darunavir/ritonavir monotherapy vs. darunavir/ritonavir with two nucleoside reverse transcriptase inhibitors in the PROTEA trial1. HIV medicine. 18 (1), pp. 5-12. [Online].